Related Experiment Video
Updated: Sep 8, 2025

Murine Distal Colostomy, A Novel Model of Diversion Colitis in C57BL/6 Mice
Published on: July 12, 2018
Malnutrition and Opioid Use Disorder Are Associated With Higher 30-day Readmission Rates in Patients Admitted for
Tarek Odah1, Pedro Palacios1, Marianny Sulbaran1,2
1Division of Gastroenterology and Hepatology, Mayo Clinic.
Hospital readmissions for ulcerative colitis (UC) are frequent, affecting 16.6% within 30 days and 28.3% within 90 days. Key predictors include comorbidities, malnutrition, and opioid use disorder, highlighting a significant burden on patients and healthcare.
Area of Science:
- Gastroenterology
- Health Services Research
- Clinical Epidemiology
Background:
- Hospital readmissions for ulcerative colitis (UC) represent a significant burden on patients and healthcare systems.
- Preventing UC readmissions is crucial for improving patient quality of life and healthcare efficiency.
Purpose of the Study:
- To determine the incidence of 30-day and 90-day hospital readmissions in ulcerative colitis (UC) patients.
- To identify independent predictors and common causes of UC readmissions.
Main Methods:
- Retrospective analysis of the 2018 National Readmission Database (NRD).
- Identification of UC patients, comorbidities, and procedures using ICD-10CM/PCS codes.
- Cox regression analysis to determine independent risk factors for readmission.
Main Results:
- UC readmission rates were 16.6% (30-day) and 28.3% (90-day).
- Predictors for 30-day readmission included higher Charlson Comorbidity Index (CCI), ileostomy, malnutrition, and opioid use disorder.
- Predictors for 90-day readmission included higher CCI, shock, colectomy, and opioid use disorder. Sepsis was the leading cause for readmission at both time points.
Conclusions:
- Readmissions in UC are linked to increased mortality and are influenced by factors like malnutrition, ileostomy, and opioid use disorder.
- UC readmissions impose a substantial burden on both patients and the healthcare system, necessitating targeted interventions.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Drugs for Treatment of Ulcerative Colitis in IBD
Chronic Pancreatitis II: Collaborative Care
Assessment:

